Asherson R A, Greenblatt M A
The Rheumatic Diseases Unit, University of Cape Town School of Medicine, Cape Town, South Africa.
J Clin Rheumatol. 2001 Feb;7(1):30-3. doi: 10.1097/00124743-200102000-00007.
Pulmonary involvement in the primary antiphospholipid syndrome (PAPS) has generally been on the basis of thromboembolism. We describe a patient with hemorrhagic alveolitis, a life-threatening complication that must also be considered. The patient was a 63-year-old Caucasian man who had a past history of recurrent deep vein thromboses as well as an arterial occlusion of the left popliteal artery and who developed hemorrhagic alveolitis and capillaritis at age 57 years, which was treated with long-term cyclophosphamide, steroids, and anticoagulation. Four years later, he had a recurrence of the same condition, and a positive lupus anticoagulant test was found. Severe thrombocytopenia, diagnosed as idiopathic thrombocytopenic purpura, was treated with platelet transfusions and increasing steroid dosage. Hemorrhagic adrenal infarction supervened at this time, and a septicemic illness was treated with intravenous antibiotics. Diffuse alveolar pulmonary hemorrhage is an unusual complication of the APS that is being increasingly reported, and recognition of its possible fatal course is of great importance for the treating physician. Severe thrombocytopenia that could contribute to hemorrhage may also accompany the APS, but this is unusual.
原发性抗磷脂综合征(PAPS)中的肺部受累通常基于血栓栓塞。我们描述了一名患有出血性肺泡炎的患者,这是一种也必须予以考虑的危及生命的并发症。该患者是一名63岁的白人男性,既往有复发性深静脉血栓形成史以及左腘动脉动脉闭塞史,57岁时出现出血性肺泡炎和毛细血管炎,接受了长期环磷酰胺、类固醇和抗凝治疗。四年后,他同样的病情复发,狼疮抗凝物检测呈阳性。诊断为特发性血小板减少性紫癜的严重血小板减少症,通过输注血小板和增加类固醇剂量进行治疗。此时发生了出血性肾上腺梗死,败血症性疾病通过静脉使用抗生素进行治疗。弥漫性肺泡肺出血是抗磷脂综合征一种不常见的并发症,且报告越来越多,认识到其可能的致命病程对治疗医生非常重要。可能导致出血的严重血小板减少症也可能伴随抗磷脂综合征出现,但这种情况并不常见。